Diallyllysergamide
From Wikipedia, the free encyclopedia
(Redirected from N,N-Diallyllysergamide)
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (6aR,9R)- N,N- diallyl- 7-methyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Controlled in the United States via the Federal Analog Act but only if it is intended for human consumption. |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| ATC code | None |
| ChemSpider | 21106294  |
| Synonyms | DAL, Lysergic acid diallylamide, d-lysergic acid diallylamide, d-diallyllysergamide |
| Chemical data | |
| Formula | C22H25N3O |
| Mol. mass | 349.467 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Diallyllysergamide (DAL, as the tartrate salt) is a psychedelic lysergamide. In their book TiHKAL, Alexander and Ann Shulgin describe it as being "an order of magnitude less potent than LSD itself".
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
